Pancreatic Cancer Research

ResearcherUniversity of MichiganActive in the last 2 years

Qiang Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5008-4327; OpenAlex author ID A5007407682. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 4

  1. Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancreatic Cancer. First author DOI 10.1158/1535-7163.mct-24-0210↗
  2. Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancer. Co-author DOI 10.1172/jci.insight.168824↗
  3. DNA-PK Inhibition and Radiation Promote Antitumoral Immunity through RNA Polymerase III in Pancreatic Cancer. Last author DOI 10.1158/1541-7786.mcr-21-0725↗
  4. Glycogen Synthase Kinase 3β in Pancreatic Cancer and its Implications in Chemotherapy and Radiation Therapy. Co-author DOI 10.4172/2157-2518.1000147↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Leslie A. Parsels · 3 shared papers, 2022–2025 · strength 0.49
  2. Theodore Steven Lawrence · 3 shared papers, 2022–2025 · strength 0.49
  3. Meredith Ann Morgan · 3 shared papers, 2022–2025 · strength 0.49
  4. Victoria M. Valvo · 2 shared papers, 2024–2025 · strength 0.35
  5. Vaibhav Sahai · 2 shared papers, 2024–2025 · strength 0.35
  6. David M. Karnak · 2 shared papers, 2022–2025 · strength 0.32
  7. Alnawaz Rehemtulla · 1 shared paper, 2025 · strength 0.18
  8. Eileen S. Carpenter · 1 shared paper, 2025 · strength 0.18
  9. Matthew T. McMillan · 1 shared paper, 2022 · strength 0.13
  10. Timothy L. Frankel · 1 shared paper, 2022 · strength 0.13
  11. Weiwei Wang · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.